Amerika Serikat - Inggris - NLM (National Library of Medicine)

bryant ranch prepack - timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - timolol anhydrous 10 mg - timolol maleate tablets are indicated for the treatment of hypertension. they may be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics. timolol is indicated in patients who have survived the acute phase of myocardial infarction, and are clinically stable, to reduce cardiovascular mortality and the risk of reinfarction. timolol is indicated for the prophylaxis of migraine headache. timolol maleate is contraindicated in patients with bronchial asthma or with a history of bronchial asthma, or severe chronic obstructive pulmonary disease (see warnings); sinus bradycardia; second- and third-degree atrioventricular block; overt cardiac failure (see warnings); cardiogenic shock; hypersensitivity to this product.

Amerika Serikat - Inggris - NLM (National Library of Medicine)

actavis pharma, inc. - brimonidine tartrate (unii: 4s9cl2dy2h) (brimonidine - unii:e6gnx3hhte), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - brimonidine tartrate/timolol maleate ophthalmic solution 0.2%/0.5% is an alpha-adrenergic receptor agonist with a beta-adrenergic receptor inhibitor indicated for the reduction of elevated intraocular pressure (iop) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop; the iop-lowering of brimonidine tartrate/timolol maleate ophthalmic solution dosed twice a day was slightly less than that seen with the concomitant administration of 0.5% timolol maleate ophthalmic solution dosed twice a day and 0.2% brimonidine tartrate ophthalmic solution dosed three times per day. brimonidine tartrate/timolol maleate ophthalmic solution is contraindicated in patients with reactive airway disease including bronchial asthma; a history of bronchial asthma; severe chronic obstructive pulmonary disease [see warnings and precautions (5.1, 5.3)] . brimonidine tartrate/timolol maleate ophthalmic solution is contraindicated in patients with sinus bradycardi

Kanada - Inggris - Health Canada

alcon canada inc - dorzolamide (dorzolamide hydrochloride); timolol (timolol maleate) - solution - 2.0%; 0.5% - dorzolamide (dorzolamide hydrochloride) 2.0%; timolol (timolol maleate) 0.5% - beta-adrenergic agents

Amerika Serikat - Inggris - NLM (National Library of Medicine)

lannett company, inc. - dorzolamide hydrochloride (unii: qzo5366ew7) (dorzolamide - unii:9jdx055tw1), timolol maleate (unii: p8y54f701r) (timolol anhydrous - unii:5jky92s7br) - dorzolamide 20 mg in 1 ml - dorzolamide hydrochloride-timolol maleate ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers (failed to achieve target iop determined after multiple measurements over time). the iop-lowering of dorzolamide hydrochloride-timolol maleate ophthalmic solution b.i.d. was slightly less than that seen with the concomitant administration of 0.5% timolol b.i.d. and 2.0% dorzolamide t.i.d. (see clinical pharmacology, clinical studies ). dorzolamide hydrochloride-timolol maleate ophthalmic solution is contraindicated in patients with (1) bronchial asthma; (2) a history of bronchial asthma; (3) severe chronic obstructive pulmonary disease (see warnings); (4) sinus bradycardia; (5) second or third degree atrioventricular block; (6) overt cardiac failure (see warnings); (7) cardiogenic shock; or (8) hypersensitivity to any component of this product. please follow  these instruction

Australia - Inggris - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - latanoprost, quantity: 0.05 mg/ml; timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: hydrochloric acid; water for injections; sodium chloride; dibasic sodium phosphate; sodium hydroxide; benzalkonium chloride; monobasic sodium phosphate monohydrate - the reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. xalacom should not be used to initiate therapy.

Kanada - Inggris - Health Canada

teva canada limited - timolol (timolol maleate); latanoprost - solution - 5mg; 50mcg - timolol (timolol maleate) 5mg; latanoprost 50mcg - beta-adrenergic agents

Kanada - Inggris - Health Canada

mylan pharmaceuticals ulc - timolol (timolol maleate); latanoprost - solution - 5mg; 50mcg - timolol (timolol maleate) 5mg; latanoprost 50mcg - beta-adrenergic agents

Kanada - Inggris - Health Canada

mint pharmaceuticals inc - timolol (timolol maleate); latanoprost - solution - 5mg; 50mcg - timolol (timolol maleate) 5mg; latanoprost 50mcg - beta-adrenergic agents

Kanada - Inggris - Health Canada

jamp pharma corporation - timolol (timolol maleate); latanoprost - solution - 5mg; 50mcg - timolol (timolol maleate) 5mg; latanoprost 50mcg - beta-adrenergic agents

Kanada - Inggris - Health Canada

apotex inc - timolol (timolol maleate); travoprost - solution - 0.5%; 0.004% - timolol (timolol maleate) 0.5%; travoprost 0.004% - beta-adrenergic agents